The gonadotropin-releasing hormone agonist leuprolide acetate induces apoptosis and suppresses cell proliferative activity in rectovaginal endometriosis
Case report
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
Leuprolide acetate, a gonadotropin-releasing hormone agonist, was found to induce apoptosis and suppress cell proliferation in rectovaginal endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A gonadotropin-releasing hormone agonist, leuprolide acetate, was administered every 4 weeks for treatment of rectovaginal endometriosis. Degrees of apoptosis (percentage of in situ deoxyribonucleic acid 3'-end-labeled cells) and cell proliferative activity (percentage of cells with immunostaining for proliferating cell protein Ki-67) were examined in endometriotic glands of biopsy specimens taken before and during gonadotropin-releasing hormone agonist therapy. Gonadotropin-releasing hormone agonist induced apoptosis and suppressed cell proliferative activity in endometriotic glands.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (2)
- Ultrastructural comparison of endometriotic implants and eutopic endometrium via openalex
- W2067911223 via openalex
Cited by (10)
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis 2013
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium 2009
- Medical treatment for rectovaginal endometriosis: what is the evidence? 2009
- Deep endometriosis: a review 2009
- Endometriosis infiltrante: revisión de tema Deep endometriosis: a review 2009
- Immunology of endometriosis 2004
- Endometriosis: a uterine disease with extrauterine lesions? 2003
- Surgical management of endometriomas—compromised ovarian function? Reply of the author 2002
- Pain increased and quality of life decreased during the first month of GnRH agonist treatment for endometriosis 2001
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T20:59:07.345995+00:00
License: CC0
· commercial use OK